Read & Publish: what authors say
There has been a great response from authors at institutions that are participating in our Read & Publish Open Access initiative.
In addition to benefitting from unlimited “read” access to Development, Journal of Cell Science and Journal of Experimental Biology and their archives, authors can publish an uncapped number of Open Access research articles without charge in Development, Journal of Cell Science and Journal of Experimental Biology. Immediate Open Access publishing also means that articles are instantly available to other researchers worldwide, regardless of institutional licensing arrangements.
Professor Geraldine Wright, Department of Zoology, University of Oxford, UK
Journal of Experimental Biology is one of my favourite journals and I was very pleased that we could publish our article Open Access without charge as a result of the R&P agreement. OA makes our research available to everyone immediately and increases the impact of our work. When you consider how much of our time and public money goes into the production of a scientific article, anything that improves its overall impact and availability amplifies its value.
Dr Matthew Walker, School of Life Sciences, University of Lincoln, UK
My university’s Read & Publish agreement with The Company of Biologists has allowed me to publish the research from my PhD in Journal of Experimental Biology without having to worry about finding funding for Open Access charges. My work is available instantly for free and can be read by JEB’s wide readership of scientists from different backgrounds.
Dr Chris MacDonald, Department of Biology, University of York, UK
The Read & Publish agreement between The Company of Biologists and The University of York is a fantastic step forward in reducing barriers to publishing – and accessing – research articles. Alongside pre-printing for early documentation of work, such mechanisms are particularly helpful for early career researchers like me. The first paper from my lab, recently accepted by Journal of Cell Science, was made available Open Access without charge through this agreement and all other aspects of the editorial process were equally simple!
Professor Fernando Montealegre-Z, School of Life Sciences, University of Lincoln, UK
Being able to publish Open Access for free in the Journal of Experimental Biology has helped us expand the readership of our research, in a very fast and convenient way. It is particularly encouraging for early career researchers at institutions with Read & Publish agreements for the journal, as it allows them to display their research globally without the need to find costs to cover the open access option.
James Briscoe, Senior Group Leader, The Francis Crick Institute, UK and Editor-in-Chief of Development:
The Read & Publish agreement is great for us at The Crick. As a corresponding author, I can publish as many papers as I like in The Company of Biologists’ journals, such as Development, without paying an Open Access charge. It also means that as a reader I have access to all The Company of Biologists’ content, dating back to the early 20th century and beyond.
Watch James Briscoe talking about what the Read & Publish agreement means for him as an author and reader in this short video.
Dr Gal Ribak, School of Zoology, Tel Aviv University, Israel:
Publishing in the Journal of Experimental Biology helps to ensure that my paper reaches colleagues in my field. Publishing my paper Open Access ensures that it will also be accessible immediately to everyone else – and it was great to be able to do so for free as my institution has a Read & Publish agreement with The Company of Biologists.
Dr Jacques Behmoaras, Department of Immunology and Inflammation, Imperial College London, UK:
I was very pleased to publish Open Access in Journal of Cell Science with no fees nor time-consuming admin processes. The clear advantages are rapid and efficient exposure and easy access to my article around the world. I believe it is great to have this publishing option in fast-growing fields in biomedical research.
Professor Talila Volk, Department of Molecular Genetics, Weizmann Institute of Science, Israel:
I was delighted to have our paper published Open Access for free in Development. This is due to a special Read & Publish deal between my research institute – the Weizmann Institute of Science – and The Company of Biologists. Publishing Open Access exposes my article to a wide variety of readers who do not have access to the journal.
Professor Sally Lowell, Centre for Regenerative Medicine, University of Edinburgh, UK:
I was delighted to have our paper accepted for publication in Development but the cherry on the cake was learning that our paper would be published Open Access for zero pounds and zero pence without me having to do anything.
I’d heard of Read & Publish deals and knew that many universities, including mine, had signed up to them but I had not previously understood the benefits that these deals bring to authors who work at those universities.
Professor Roi Holzman, Department of Zoology, Tel Aviv University, Israel:
Being able to publish Open Access articles free of charge means that my article gets maximum exposure and has maximum impact, and that all my peers can read it regardless of the agreements that their universities have with publishers. Besides the better exposure, it allows me divert more resources to research, so the benefit is doubled.
Professor Shankar Srinivas, Department of Physiology, Anatomy & Genetics, University of Oxford, UK:
It’s wonderful to be able to publish in a journal like Development for ‘free’. The best part for me was how painless the digital paperwork was – the web form is brief and takes very little time to fill out.